MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
NVST stock logo

NVST

Envista Holdings Corp

$24.59
1.15
 (4.91%)
Exchange:  NYSE
Market Cap:  4.001B
Shares Outstanding:  154.6M
Delayed data
Calculate NVST Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Equipment & Services
   
CEO:  Paul A. Keel
Full Time Employees:  12300
Address: 
200 S Kraemer Blvd Bldg E
Brea
CA
92821-6208
US
Website:  http://www.envistaco.com
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company’s principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: “Specialty Products & Technologies” and “Equipment & Consumables.” The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/06 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue2,566,5002,510,6002,719,500
Gross Profit1,450,5001,391,6001,496,300
EBITDA463,000279,500341,700
Operating Income31,500-1,038,200225,700
Net Income-100,200-1,118,60047,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets6,605,1005,350,5005,679,000
Total Liabilities2,431,2002,415,7002,572,700
Total Stockholders Equity4,173,9002,934,8003,106,300
Total Debt1,653,6001,547,7001,597,700
Cash and Cash Equivalents940,0001,069,1001,211,700

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow275,700336,500275,700
Capital Expenditure-58,200-33,800-45,300
Free Cash Flow217,500302,700230,400
Net Income-100,200-1,118,60047,000
Net Change in Cash333,100129,1000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2029Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)3,143,112.492Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)3,218,972.716Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)3,173,050Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)508,429.261Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)520,700.396Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)513,271.947Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)318,371.797Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)328,390.129Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)322,326.001Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,303,488.899Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,334,949.103Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,315,904.366Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)1.910Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)1.940Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)1.880Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)5Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)2Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
2.511B  ?P/S
 (TTM)
: 
1.34
?Net Income
 (TTM)
: 
-1118600000  ?P/E
 (TTM)
: 
55.92
?Enterprise Value
 (TTM)
: 
4.265B  ?EV/FCF
 (TTM)
: 
19.37
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.02  ?ROIC
 (TTM)
: 
0.02
?Net Debt
 (TTM)
: 
478.6M  ?Debt/Equity
 (TTM)
: 
0.52
?P/B
 (TTM)
: 
1.23  ?Current Ratio
 (TTM)
: 
2.44

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
17.20Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates NVST intrinsic value between $10.67 – $25.87 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about NVST valuation

Is Envista Holdings Corp (NVST) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Envista Holdings Corp (NVST) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is NVST a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether NVST trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is NVST’s P/E ratio?

You can see NVST’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for NVST?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is NVST a good long-term investment?

Whether NVST fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

NVST

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

4.91
MARKETSnap

Trading Metrics:

Open: 23.73   Previous Close: 23.44
Day Low: 23.69   Day High: 25.03
Year Low: 18.25   Year High: 30.42
Price Avg 50: 25.13   Price Avg 200: 23.31
Volume: 2.828M   Average Volume: 2.961M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Is NVST Attractive at 15.1x Forward Earnings?
04-06-2026 12:55
Is NVST Attractive at 15.1x Forward Earnings?
Envista Q1 Earnings Call Highlights
13-05-2026 05:06
Envista Q1 Earnings Call Highlights
Envista (NVST) International Revenue Performance Explored
11-05-2026 10:16
Envista (NVST) International Revenue Performance Explored
Envista Schedules First Quarter 2026 Earnings Call
08-04-2026 16:10
Envista Schedules First Quarter 2026 Earnings Call
Envista Stock Up 42.5% in a Year: What's Driving It?
30-03-2026 11:57
Envista Stock Up 42.5% in a Year: What's Driving It?
NVST or SYK: Which Is the Better Value Stock Right Now?
23-03-2026 12:40
NVST or SYK: Which Is the Better Value Stock Right Now?

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read